| Accelerating the discovery of novel drugs for chemo-resistant cancer

AdenoCure 3X is a reliable and easy-to-use in vitro cell viability assay kit for apoptotic signaling research and cancer therapeutic drug discovery. This kit provides a convenient and reliable method to assess cell viability in response to various stimuli, making it ideal for studying apoptosis induction and drug screening. 

The core component of AdenoCure 3X is a recombinant adenovirus (Ad-MBRG) encoding tumor suppressor genes: HA-tagged MOAP-1, Bax, and RASSF1A. This unique combination allows researchers to investigate the specific effects of these genes on the apoptotic pathway in cancer cells. The Ad-MBRG vector also includes an EGFP reporter gene. 

This enables easy visualization and quantification of cell viability or death through changes in green fluorescent protein expression. The assay kit boasts an optimized protocol for efficient assay setup and execution. This ensures reliable results and user-friendliness for researchers of all experience levels. 

| Accelerating drug discovery through predictive modelling platforms and in silico intelligence

The in silico modelling platforms are designed to accelerate drug discovery through data-driven molecular design and property prediction. By simulating chemical behavior computationally, the platforms enables researchers to explore vast chemical spaces, prioritize candidate molecules, and predict pharmacologically relevant properties prior to the costly and time-consuming lab experiments.

Whether used for early-stage hit identification or late-stage optimization, the platforms empowers researchers with a scalable, interpretable, and efficient computational framework for modern drug discovery.